Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FOLD | XENE | IDYA | ||
| Company | Amicus Therapeutics | Xenon Pharmaceuticals Inc | Ideaya Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.26 | 40.02 | 38.90 | ||
| High | 10.32 | 40.87 | 40.36 | ||
| Low | 10.11 | 39.80 | 38.11 | ||
| Last | 10.28 | 40.50 | 39.94 | ||
| Change | +0.11 | +0.40 | +1.32 | ||
| % Change | +1.08% | +1.00% | +3.42% | ||
| Volume | 1,714,700 | 320,700 | 619,300 | ||
| 20-Day Average Volume | 2,747,880 | 315,885 | 594,710 | ||
| Previous Close | 10.17 | 40.10 | 38.62 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.97 | 41.38 | 40.75 | ||
| 20-Day Raw Stochastic | 14.44% | 37.08% | 43.81% | ||
| 20-Day Relative Strength | 35.87% | 41.69% | 45.64% | ||
| Weighted Alpha | -18.00 | -4.64 | +99.40 | ||
| Today's Opinion | 80% Sell | 8% Sell | 24% Buy | ||
| Previous Opinion | 72% Sell | 8% Sell | 24% Buy | ||
| Last Month's Opinion | 56% Sell | 40% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.11% since 04/19/24 | +1.55% since 04/19/24 | +7.57% since 04/19/24 | ||
| Low | 10.02 on 04/25/24 | 38.85 on 04/25/24 | 36.85 on 04/22/24 | ||
| High | 10.93 on 04/23/24 | 41.59 on 04/23/24 | 40.36 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | -10.06% since 03/26/24 | -5.06% since 03/26/24 | -6.05% since 03/26/24 | ||
| Low | 10.02 on 04/25/24 | 38.85 on 04/25/24 | 36.58 on 04/19/24 | ||
| High | 11.93 on 03/28/24 | 43.54 on 03/28/24 | 44.25 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | -16.69% since 01/26/24 | -11.26% since 01/26/24 | -5.33% since 01/26/24 | ||
| Low | 10.02 on 04/25/24 | 38.85 on 04/25/24 | 36.58 on 04/19/24 | ||
| High | 14.03 on 02/15/24 | 50.99 on 03/01/24 | 47.74 on 02/15/24 | ||
| 6-Month | |||||
| %Chg | -5.34% since 10/26/23 | +30.06% since 10/26/23 | +47.60% since 10/26/23 | ||
| Low | 9.70 on 11/10/23 | 27.99 on 11/13/23 | 25.22 on 10/30/23 | ||
| High | 14.57 on 12/28/23 | 50.99 on 03/01/24 | 47.74 on 02/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,044,689 | 3,054,996 | 2,986,114 | ||
| Shares Outstanding, K | 296,176 | 75,432 | 74,765 | ||
| Annual Sales | 399,360,000 | 0 | 23,390,000 | ||
| Annual Net Income | -151,580,000 | -182,390,000 | -112,960,000 | ||
| Last Quarter Sales | 115,080,000 | 0 | 3,920,000 | ||
| Last Quarter Net Income | -33,840,000 | -44,740,000 | -33,950,000 | ||
| 60-Month Beta | 0.75 | 1.15 | 0.80 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 02/28/24 | -0.64 on 02/29/24 | -0.52 on 02/20/24 | ||
| Latest Earnings Date | 05/08/24 | 05/14/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||